SGX PHARMACEUTICALS, INC. 4
4 · SGX PHARMACEUTICALS, INC. · Filed Sep 17, 2007
Insider Transaction Report
Form 4
Reich Siegfried
VP, Drug Discovery
Transactions
- Exercise/Conversion
Restricted Stock Units
2007-09-17−1,563→ 43,750 total→ Common Stock (1,563 underlying) - Sale
Common Stock
2007-09-17$6.20/sh−781$4,842→ 15,627 total - Exercise/Conversion
Common Stock
2007-09-17+1,563→ 16,408 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2006.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]25% of the restricted stock units vest on January 15, 2007. The remaining restricted stock units vest in equal monthly installments over the following 3 years.